Insider trades
Justin B. Klee, CEO of Amylyx Pharmaceuticals AMLX, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $2.6M. The latest trade was on 03/05.
Justin B. Klee
Co-CEO
- Company
- Amylyx Pharmaceuticals AMLX
- First filing
- 23/01/10
- Trades
- 36 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- −$2.6M
- Last trade
- 03/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/02 | 03/04 | 29,282 sh | $14.47 | $423,710.54 | −0.9% | |
| Open-market sale | 02/02 | 02/04 | 15,500 sh | $14.69 | $227,695 | −0.5% | |
AMLX | Open-market sale | 01/15–01/16 | 01/20 | 138,188 sh2 trades | $13.58avg. | $1,877,211.49 | −3.9% |
| Open-market sale | 01/06 | 01/08 | 7,715 sh | $11.09 | $85,559.35 | −0.2% | |
AMLX | Open-market sale | 25/09/30 | 25/10/02 | 29,975 sh2 trades | $14.37avg. | $430,868.75 | −0.9% |
| Open-market sale | 25/03/31 | 25/04/02 | 21,490 sh | $3.46 | $74,355.4 | −0.6% | |
| Open-market sale | 25/03/03 | 25/03/05 | 4,595 sh | $3.15 | $14,474.25 | −0.1% | |
| Open-market sale | 25/02/03 | 25/02/05 | 11,855 sh | $3.47 | $41,136.85 | −0.4% | |
| Open-market sale | 25/01/06 | 25/01/08 | 7,471 sh | $4.04 | $30,182.84 | −0.2% | |
| Open-market sale | 24/09/30 | 24/10/02 | 18,589 sh | $3.20 | $59,484.8 | −0.6% | |
| Open-market sale | 24/03/05 | 24/03/07 | 4,135 sh | $18.73 | $77,448.55 | −0.1% | |
| Open-market sale | 24/01/09 | 24/01/11 | 5,841 sh | $16.33 | $95,383.53 | −0.2% | |
AMLX | Open-market sale | 23/03/16 | 23/03/20 | 100,000 sh2 trades | $31.86avg. | $3,186,204.8 | −3.5% |
AMLX | Open-market sale | 23/01/06 | 23/01/10 | 5,968 sh2 trades | $36.30avg. | $216,636.1 | +0.2% |